Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Hoelzer

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Seminars in Hematology|December 23, 2008
Treatment of adult acute lymphoblastic leukemiaNicola Gökbuget, Dieter Hoelzer
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Current Clinical Practice: Current Therapeutic Options in Myelodysplastic SyndromesWOLF-KARSTEN Hofmann, DIETER Hoelzer
Seminars in Oncology|December 19, 2007
Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignanciesRichard R Furman, Dieter Hoelzer
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
The ABL tyrosine kinase inhibitor STI571 (Glivec) in Philadelphia positive acute lymphoblastic leukemia - promises, pitfalls and possibilitiesOliver G Ottmann, Dieter Hoelzer
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2018
"Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALLSabina Chiaretti, Elias Jabbour, Dieter Hoelzer
Cancer Treatment and Research|November 6, 2010
The hematopoietic growth factors in acute leukemia: a European perspectiveMichael Heuser, Arnold Ganser, Dieter Hoelzer
Bone Marrow Transplantation|June 2, 2018
Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemiaCharles Craddock, Dieter Hoelzer, Krishna V Komanduri
Medizinische Klinik (Munich, Germany : 1983)|February 8, 2002
[Therapy of Philadelphia chromosome positive acute lymphatic leukemia (Ph+ ALL) with an inhibitor of abl-tyrosine kinase (Glivec)]Oliver G Ottmann, Barbara Wassmann, Dieter Hoelzer
Seminars in Hematology|November 26, 2002
Targeted therapies in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaDieter Hoelzer, Nicola Gökbuget, Oliver G Ottmann
European Journal of Immunology|March 3, 2004
Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cellsNoriko Koyama, Dieter Hoelzer, Oliver G Ottmann
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Seminars in Hematology|December 23, 2008
Treatment of adult acute lymphoblastic leukemiaNicola Gökbuget, Dieter Hoelzer
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Current Clinical Practice: Current Therapeutic Options in Myelodysplastic SyndromesWOLF-KARSTEN Hofmann, DIETER Hoelzer
Seminars in Oncology|December 19, 2007
Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignanciesRichard R Furman, Dieter Hoelzer
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
The ABL tyrosine kinase inhibitor STI571 (Glivec) in Philadelphia positive acute lymphoblastic leukemia - promises, pitfalls and possibilitiesOliver G Ottmann, Dieter Hoelzer
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2018
"Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALLSabina Chiaretti, Elias Jabbour, Dieter Hoelzer
Cancer Treatment and Research|November 6, 2010
The hematopoietic growth factors in acute leukemia: a European perspectiveMichael Heuser, Arnold Ganser, Dieter Hoelzer
Bone Marrow Transplantation|June 2, 2018
Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemiaCharles Craddock, Dieter Hoelzer, Krishna V Komanduri
Medizinische Klinik (Munich, Germany : 1983)|February 8, 2002
[Therapy of Philadelphia chromosome positive acute lymphatic leukemia (Ph+ ALL) with an inhibitor of abl-tyrosine kinase (Glivec)]Oliver G Ottmann, Barbara Wassmann, Dieter Hoelzer
Seminars in Hematology|November 26, 2002
Targeted therapies in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaDieter Hoelzer, Nicola Gökbuget, Oliver G Ottmann
European Journal of Immunology|March 3, 2004
Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cellsNoriko Koyama, Dieter Hoelzer, Oliver G Ottmann
Pageof 23